Berenson JR - Search Results

1

Risk of skin cancer in multiple myeloma patients: a retrospective cohort study.

Robinson AA, Wang J, Vardanyan S, Madden EK, Hebroni F, Udd KA, Spektor TM, Nosrati JD, Kitto AZ, Zahab M, Cheema S, Fors DH, Norberg A, Diehl J, Waterman GN, Swift RA, Crowley J, Berenson JR. Robinson AA, et al. Among authors: berenson jr. Eur J Haematol. 2016 Nov;97(5):439-444. doi: 10.1111/ejh.12748. Epub 2016 Mar 7. Eur J Haematol. 2016. PMID: 26872804

2

Multiple myeloma: the cells of origin--a two-way street.

Berenson JR, Vescio RA, Said J. Berenson JR, et al. Leukemia. 1998 Feb;12(2):121-7. doi: 10.1038/sj.leu.2400947. Leukemia. 1998. PMID: 9519771 Review.

3

Methylation of the p16INK4A gene in multiple myeloma.

Tasaka T, Asou H, Munker R, Said JW, Berenson J, Vescio RA, Nagai M, Takahara J, Koeffler HP. Tasaka T, et al. Br J Haematol. 1998 Jun;101(3):558-64. doi: 10.1046/j.1365-2141.1998.00724.x. Br J Haematol. 1998. PMID: 9633902 Free article.

4

Recent advances in the treatment of multiple myeloma.

Henick K, Vescio RA, Berenson JR. Henick K, et al. Among authors: berenson jr. Curr Opin Hematol. 1998 Jul;5(4):254-8. doi: 10.1097/00062752-199807000-00004. Curr Opin Hematol. 1998. PMID: 9747631 Review.

5

Initiation and maintenance of multiple myeloma.

Berenson JR, Bergsagel PL, Munshi N. Berenson JR, et al. Semin Hematol. 1999 Jan;36(1 Suppl 3):9-13. Semin Hematol. 1999. PMID: 9989483 Review.

6

A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.

Berenson JR, Vescio R, Henick K, Nishikubo C, Rettig M, Swift RA, Conde F, Von Teichert JM. Berenson JR, et al. Cancer. 2001 Jan 1;91(1):144-54. doi: 10.1002/1097-0142(20010101)91:1<144::aid-cncr19>3.0.co;2-q. Cancer. 2001. PMID: 11148571 Clinical Trial.

7

Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients.

Berenson JR, Crowley JJ, Grogan TM, Zangmeister J, Briggs AD, Mills GM, Barlogie B, Salmon SE. Berenson JR, et al. Blood. 2002 May 1;99(9):3163-8. doi: 10.1182/blood.v99.9.3163. Blood. 2002. PMID: 11964279 Free article. Clinical Trial.

8

Overcoming drug resistance in multiple myeloma: the emergence of therapeutic approaches to induce apoptosis.

Yang HH, Ma MH, Vescio RA, Berenson JR. Yang HH, et al. Among authors: berenson jr. J Clin Oncol. 2003 Nov 15;21(22):4239-47. doi: 10.1200/JCO.2003.06.001. J Clin Oncol. 2003. PMID: 14615454 Review.

9

Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.

Unger JM, LeBlanc M, Crowley JJ, Grossman HB, Natale RB, Wozniak AJ, Berenson JR, List AF, Peters WA 3rd, Flanigan RC, Macdonald JS, Al-Sarraf M, Thompson IM, Coltman CA Jr. Unger JM, et al. Among authors: berenson jr. J Clin Oncol. 2003 Dec 1;21(23 Suppl):246s-252s. doi: 10.1200/JCO.2003.08.512. J Clin Oncol. 2003. PMID: 14645404

10

A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma.

Berenson JR, Swift RA, Ferretti D, Purner MB. Berenson JR, et al. Clin Lymphoma. 2004 Sep;5(2):130-4. doi: 10.3816/clm.2004.n.020. Clin Lymphoma. 2004. PMID: 15453931 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters